419 related articles for article (PubMed ID: 17714558)
21. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
22. Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions.
Wenzel J; Bekisch B; Uerlich M; Haller O; Bieber T; Tüting T
Am J Clin Pathol; 2005 Jul; 124(1):37-48. PubMed ID: 15923172
[TBL] [Abstract][Full Text] [Related]
23. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus.
McNiff JM; Kaplan DH
J Cutan Pathol; 2008 May; 35(5):452-6. PubMed ID: 18005168
[TBL] [Abstract][Full Text] [Related]
24. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
Caproni M; Torchia D; Antiga E; Giomi B; Mercuri M; Volpi W; Fabbri P
J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371
[TBL] [Abstract][Full Text] [Related]
25. Clinic and pathophysiology of photosensitivity in lupus erythematosus.
Lehmann P; Homey B
Autoimmun Rev; 2009 May; 8(6):456-61. PubMed ID: 19167524
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus.
Naschberger E; Wenzel J; Kretz CC; Herrmann M; Stürzl M; Kuhn A
Exp Dermatol; 2011 Feb; 20(2):102-6. PubMed ID: 21121962
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
28. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
Tebbe B; Orfanos CE
Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
[TBL] [Abstract][Full Text] [Related]
29. Enhanced CCR5+/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus.
Freutel S; Gaffal E; Zahn S; Bieber T; Tüting T; Wenzel J
Lupus; 2011 Oct; 20(12):1300-4. PubMed ID: 21844117
[TBL] [Abstract][Full Text] [Related]
30. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O
J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
[TBL] [Abstract][Full Text] [Related]
31. Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea.
Ghoreishi M; Vera Kellet C; Dutz JP
Exp Dermatol; 2012 Jun; 21(6):417-9. PubMed ID: 22507598
[TBL] [Abstract][Full Text] [Related]
32. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
[TBL] [Abstract][Full Text] [Related]
33. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
34. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate.
Lourenço SV; de Carvalho FR; Boggio P; Sotto MN; Vilela MA; Rivitti EA; Nico MM
J Cutan Pathol; 2007 Jul; 34(7):558-64. PubMed ID: 17576335
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus--relation to immunopathological mechanisms.
Tebbe B; Mazur L; Stadler R; Orfanos CE
Br J Dermatol; 1995 Jan; 132(1):25-31. PubMed ID: 7756149
[TBL] [Abstract][Full Text] [Related]
36. Plasmacytoid dendritic cells are absent in skin lesions of polymorphic light eruption.
Wackernagel A; Massone C; Hoefler G; Steinbauer E; Kerl H; Wolf P
Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):24-8. PubMed ID: 17254032
[TBL] [Abstract][Full Text] [Related]
37. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
38. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
Wenzel J; Henze S; Brähler S; Bieber T; Tüting T
Exp Dermatol; 2005 Jun; 14(6):454-9. PubMed ID: 15885081
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus.
Zahn S; Rehkämper C; Kümmerer BM; Ferring-Schmidt S; Bieber T; Tüting T; Wenzel J
J Invest Dermatol; 2011 Jan; 131(1):133-40. PubMed ID: 20720564
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
